BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20345222)

  • 21. Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide.
    Donato V; Papaleo A; Castrichino A; Banelli E; Giangaspero F; Salvati M; Delfini R
    Tumori; 2007; 93(3):248-56. PubMed ID: 17679459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?
    Kimple RJ; Grabowski S; Papez M; Collichio F; Ewend MG; Morris DE
    Am J Clin Oncol; 2010 Jun; 33(3):265-70. PubMed ID: 19823072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
    Grossman SA; Ye X; Piantadosi S; Desideri S; Nabors LB; Rosenfeld M; Fisher J;
    Clin Cancer Res; 2010 Apr; 16(8):2443-9. PubMed ID: 20371685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.
    Combs SE; Heeger S; Haselmann R; Edler L; Debus J; Schulz-Ertner D
    BMC Cancer; 2006 May; 6():133. PubMed ID: 16709245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudoprogression following chemoradiotherapy for glioblastoma multiforme.
    Sanghera P; Perry J; Sahgal A; Symons S; Aviv R; Morrison M; Lam K; Davey P; Tsao MN
    Can J Neurol Sci; 2010 Jan; 37(1):36-42. PubMed ID: 20169771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
    Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
    J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma.
    Yusuf M; Ugiliweneza B; Amsbaugh M; Boakye M; Williams B; Nelson M; Hattab EM; Woo S; Burton E
    Oncology; 2018; 95(1):39-42. PubMed ID: 29694955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide.
    Fiorica F; Berretta M; Colosimo C; Stefanelli A; Ursino S; Zanet E; Palmucci T; Maugeri D; Malaguarnera M; Palmucci S; Grasso M; Tirelli U; Cartei F
    Arch Gerontol Geriatr; 2010; 51(1):31-5. PubMed ID: 19628288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
    Combs SE; Gutwein S; Schulz-Ertner D; van Kampen M; Thilmann C; Edler L; Wannenmacher MM; Debus J
    Strahlenther Onkol; 2005 Jun; 181(6):372-7. PubMed ID: 15925979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
    Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
    Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.
    Kocher M; Frommolt P; Borberg SK; Rühl U; Steingräber M; Niewald M; Staar S; Stuschke M; Becker G; Fischedick AR; Herfarth K; Grauthoff H; Müller RP
    Strahlenther Onkol; 2008 Nov; 184(11):572-9. PubMed ID: 19016015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomide.
    Weiler M; Hartmann C; Wiewrodt D; Herrlinger U; Gorlia T; Bähr O; Meyermann R; Bamberg M; Tatagiba M; von Deimling A; Weller M; Wick W
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):670-6. PubMed ID: 19836157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: a retrospective study.
    Sridhar T; Gore A; Boiangiu I; Machin D; Symonds RP
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):19-22. PubMed ID: 18838255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated adjuvant anti-CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long-term efficacy results of a prospective phase 2 study.
    Sahlmann CO; Homayounfar K; Niessner M; Dyczkowski J; Conradi LC; Braulke F; Meller B; Beißbarth T; Ghadimi BM; Meller J; Goldenberg DM; Liersch T
    Cancer; 2017 Feb; 123(4):638-649. PubMed ID: 27763687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients.
    Wang TJ; Jani A; Estrada JP; Ung TH; Chow DS; Soun JE; Saad S; Qureshi YH; Gartrell R; Isaacson SR; Cheng SK; McKhann GM; Bruce JN; Lassman AB; Sisti MB
    Neurosurgery; 2016 May; 78(5):676-82. PubMed ID: 26440447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
    Hainsworth JD; Ervin T; Friedman E; Priego V; Murphy PB; Clark BL; Lamar RE
    Cancer; 2010 Aug; 116(15):3663-9. PubMed ID: 20564147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy.
    Back MF; Ang EL; Ng WH; See SJ; Lim CC; Chan SP; Yeo TT
    Ann Acad Med Singap; 2007 May; 36(5):338-42. PubMed ID: 17549280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide.
    Minniti G; Scaringi C; Baldoni A; Lanzetta G; De Sanctis V; Esposito V; Enrici RM
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):285-91. PubMed ID: 23642624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.